Dr Lillian Dipnall is a neuroscientist and research commercialisation advisor specialising in translating technologies from lab to market. Her expertise spans neuroscience, clinical trials, IP strategy, and venture development, connecting scientific innovation with industry, investment, and real-world outcomes. She is driven by advancing solutions that tackle complex clinical and societal challenges through sustainable, impact-focused pathways.

Ludovic Labat, Ph.D., is the CEO of Neo-Bionica, an advanced MedTech contract engineering and manufacturing consultancy headquartered in Melbourne, Australia and serving clients in countries around the world.

As a business leader, Ludovic has over 20 years’ experience in the medical device and technology industry in Europe, the US, and Asia Pacific with a range of global companies including Fortive, Danaher, Siemens, Tektronix, and Invetech. He has a record of proven success in bringing innovations to market and generating profitable growth in global high-tech and medical device markets.